Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1994 | 03-1994 | 12-1993 | 09-1993 | 06-1993 | |
| Sales | 93 | 92 | 178 | 171 | 160 |
| Cost of Goods | 0 | 0 | 20,641 | 0 | 0 |
| Gross Profit | 93 | 24 | -20,577 | 21 | 39 |
| Operating Expenses | 3,498 | 3,909 | -9,981 | 5,160 | 4,572 |
| Operating Income | -3,406 | -3,817 | -9,841 | -4,989 | -4,412 |
| Interest Expense | 11 | 10 | 11 | 12 | 23 |
| Other Income | 77 | 0 | 0 | -1 | 0 |
| Pre-tax Income | -3,340 | -3,827 | -9,852 | -5,001 | -4,435 |
| Net Income Continuous | -3,340 | -3,287 | -9,853 | -5,001 | -4,435 |
| Net Income | $-3,340 | $-3,287 | $-9,853 | $-5,001 | $-4,435 |
| EPS Basic Total Ops | N/A | -5.50 | -14.00 | -7.00 | -7.50 |
| EPS Basic Continuous Ops | N/A | -32,870.00 | -98,530.00 | -50,010.00 | -44,350.00 |
| EPS Diluted Total Ops | -33,397.00 | -5.50 | -14.00 | -7.00 | -7.50 |
| EPS Diluted Continuous Ops | -33,397.00 | -32,870.00 | -98,530.00 | -50,010.00 | -44,350.00 |
| EBITDA(a) | $-3,406 | $-3,817 | $-9,841 | $-4,989 | $-4,412 |